BioPharma Credit PLC
BPCP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £1,028 | £1,060 | £1,056 | £1,177 |
| - Cash | £4 | £6 | £37 | £135 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £1,024 | £1,054 | £1,019 | £1,042 |
| Revenue | £56 | £45 | £79 | £57 |
| % Growth | 24% | -42.7% | 38.3% | – |
| Gross Profit | £84 | £45 | £79 | £57 |
| % Margin | 149.1% | 100% | 100% | 100% |
| EBITDA | £53 | £0 | £0 | -£0 |
| % Margin | 94.3% | 0% | 0% | -0% |
| Net Income | £53 | £50 | £72 | £38 |
| % Margin | 94.3% | 111.1% | 90.8% | 65.6% |
| EPS Diluted | 0.046 | 0.042 | 0.058 | 0.029 |
| % Growth | 9.8% | -27.2% | 100.3% | – |
| Operating Cash Flow | £25 | £64 | £48 | £93 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | £25 | £64 | £48 | £93 |